Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016 a systematic analysis for the global burden of disease study global burden of disease cancer collaboration

Christina Fitzmaurice; Tomi F. Akinyemiju; Faris Hasan Al Lami; Tahiya Alam; Reza Alizadeh-Navaei; Christine Allen; Ubai Alsharif; Nelson Alvis-Guzman; Erfan Amini; Benjamin O. Anderson; Olatunde Aremu; Al Artaman; Solomon Weldegebreal Asgedom; Reza Assadi; Tesfay Me Hari Atey; Leticia Avila-Burgos; Ashish Awasthi; Huda Omerba Saleem; Aleksandra Barac; James R. Bennett; Isabela M. Bensenor; Nickhill Bhakta; Hermann Brenner; Lucero Cahuana-Hurtado; Carlos A. Castañeda-Orjuela; Ferrán Catalá-López; Jee Young Jasmine Choi; Devasahayam Jesudas Christopher; Sheng Chia Chung; Maria Paula Curado; Lalit Dandona; Rakhi Dandona; José Das Neves; Subhojit Dey; Samath D. Dharmaratne; David Teye Doku; Tim R. Driscoll; Manisha Dubey; Hedyeh Ebrahimi; Dumessa Edessa; Ziad El-Khatib; Aman Yesuf Endries; Florian Fischer; Lisa M. Force; Kyle J. Foreman; Solomon Weldemariam Gebrehiwot; Sameer Vali Gopalani; Giuseppe Grosso; Rahul Gupta; Bishal Gyawali; Randah Ribhi Hamadeh; Samer Hamidi; James Harvey; Hamid Yimam Hassen; Roderick J. Hay; Simon I. Hay; Behzad Heibati; Molla Kahssay Hiluf; Nobuyuki Horita; H. Dean Hosgood; Olayinka S. Ilesanmi; Kaire Innos; Farhad Islami; Mihajlo B. Jakovljevic; Sarah Charlotte Johnson; Jost B. Jonas; Amir Kasaeian; Tesfaye Dessale Kassa; Yousef Saleh Khader; Ejaz Ahmad Khan; Gulfaraz Khan; Young Ho Khang; Mohammad Hossein Khosravi; Jagdish Khubchandani; Jacek A. Kopec; G. Anil Kumar; Michael Kutz; Deepesh Pravinkumar Lad; Alessandra Lafranconi; Qing Lan; Yirga Legesse; James Leigh; Shai Linn; Raimundas Lunevicius; Azeem Majeed; Reza Malekzadeh; Deborah Carvalho Malta; Lorenzo G. Mantovani; Brian J. McMahon; Toni Meier; Yohannes Adama Melaku; Mulugeta Melku; Peter Memiah; Walter Mendoza; Tuomo J. Meretoja; Haftay Berhane Mezgebe; Ted R. Miller; Shafiu Mohammed; Ali H. Mokdad; Mahmood Moosazadeh; Paula Moraga; Seyyed Meysam Mousavi; Vinay Nangia; Cuong Tat Nguyen; Vuong Minh Nong; Felix Akpojene Ogbo; Andrew Toyin Olagunju; P. A. Mahesh; Eun Kee Park; Tejas Patel; David M. Pereira; Farhad Pishgar; Maarten J. Postma; Farshad Pourmalek; Mostafa Qorbani; Anwar Rafay; Salman Rawaf; David Laith Rawaf; Gholamreza Roshandel; Saeid Safiri; Hamideh Salimzadeh; Juan Ramon Sanabria; Milena M.Santric Milicevic; Benn Sartorius; Maheswar Satpathy; Sadaf G. Sepanlou; Katya Anne Shackelford; Masood Ali Shaikh; Mahdi Sharif-Alhoseini; Jun She; Min Jeong Shin; Ivy Shiue; Mark G. Shrime; Abiy Hiruye Sinke; Mekonnen Sisay; Amber Sligar; Muawiyyah Babale Sufiyan; Bryan L. Sykes; Rafael Tabarés-Seisdedos; Gizachew Assefa Tessema; Roman Topor-Madry; Tung Thanh Tran; Bach Xuan Tran; Kingsley Nnanna Ukwaja; Vasiliy Victorovich Vlassov; Stein Emil Vollset; Elisabete Weiderpass; Hywel C. Williams; Nigus Bililign Yimer; Naohiro Yonemoto; Mustafa Z. Younis; Christopher J.L. Murray; Mohsen Naghavi

doi:10.1001/jamaoncol.2018.2706

Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016 a systematic analysis for the global burden of disease study global burden of disease cancer collaboration

Christina Fitzmaurice, Tomi F. Akinyemiju, Faris Hasan Al Lami, Tahiya Alam, Reza Alizadeh-Navaei, Christine Allen, Ubai Alsharif, Nelson Alvis-Guzman, Erfan Amini, Benjamin O. Anderson, Olatunde Aremu, Al Artaman, Solomon Weldegebreal Asgedom, Reza Assadi, Tesfay Me Hari Atey, Leticia Avila-Burgos, Ashish Awasthi, Huda Omerba Saleem, Aleksandra Barac, James R. BennettIsabela M. Bensenor, Nickhill Bhakta, Hermann Brenner, Lucero Cahuana-Hurtado, Carlos A. Castañeda-Orjuela, Ferrán Catalá-López, Jee Young Jasmine Choi, Devasahayam Jesudas Christopher, Sheng Chia Chung, Maria Paula Curado, Lalit Dandona, Rakhi Dandona, José Das Neves, Subhojit Dey, Samath D. Dharmaratne, David Teye Doku, Tim R. Driscoll, Manisha Dubey, Hedyeh Ebrahimi, Dumessa Edessa, Ziad El-Khatib, Aman Yesuf Endries, Florian Fischer, Lisa M. Force, Kyle J. Foreman, Solomon Weldemariam Gebrehiwot, Sameer Vali Gopalani, Giuseppe Grosso, Rahul Gupta, Bishal Gyawali, Randah Ribhi Hamadeh, Samer Hamidi, James Harvey, Hamid Yimam Hassen, Roderick J. Hay, Simon I. Hay, Behzad Heibati, Molla Kahssay Hiluf, Nobuyuki Horita, H. Dean Hosgood, Olayinka S. Ilesanmi, Kaire Innos, Farhad Islami, Mihajlo B. Jakovljevic, Sarah Charlotte Johnson, Jost B. Jonas, Amir Kasaeian, Tesfaye Dessale Kassa, Yousef Saleh Khader, Ejaz Ahmad Khan, Gulfaraz Khan, Young Ho Khang, Mohammad Hossein Khosravi, Jagdish Khubchandani, Jacek A. Kopec, G. Anil Kumar, Michael Kutz, Deepesh Pravinkumar Lad, Alessandra Lafranconi, Qing Lan, Yirga Legesse, James Leigh, Shai Linn, Raimundas Lunevicius, Azeem Majeed, Reza Malekzadeh, Deborah Carvalho Malta, Lorenzo G. Mantovani, Brian J. McMahon, Toni Meier, Yohannes Adama Melaku, Mulugeta Melku, Peter Memiah, Walter Mendoza, Tuomo J. Meretoja, Haftay Berhane Mezgebe, Ted R. Miller, Shafiu Mohammed, Ali H. Mokdad, Mahmood Moosazadeh, Paula Moraga, Seyyed Meysam Mousavi, Vinay Nangia, Cuong Tat Nguyen, Vuong Minh Nong, Felix Akpojene Ogbo, Andrew Toyin Olagunju, P. A. Mahesh, Eun Kee Park, Tejas Patel, David M. Pereira, Farhad Pishgar, Maarten J. Postma, Farshad Pourmalek, Mostafa Qorbani, Anwar Rafay, Salman Rawaf, David Laith Rawaf, Gholamreza Roshandel, Saeid Safiri, Hamideh Salimzadeh, Juan Ramon Sanabria, Milena M.Santric Milicevic, Benn Sartorius, Maheswar Satpathy, Sadaf G. Sepanlou, Katya Anne Shackelford, Masood Ali Shaikh, Mahdi Sharif-Alhoseini, Jun She, Min Jeong Shin, Ivy Shiue, Mark G. Shrime, Abiy Hiruye Sinke, Mekonnen Sisay, Amber Sligar, Muawiyyah Babale Sufiyan, Bryan L. Sykes, Rafael Tabarés-Seisdedos, Gizachew Assefa Tessema, Roman Topor-Madry, Tung Thanh Tran, Bach Xuan Tran, Kingsley Nnanna Ukwaja, Vasiliy Victorovich Vlassov, Stein Emil Vollset, Elisabete Weiderpass, Hywel C. Williams, Nigus Bililign Yimer, Naohiro Yonemoto, Mustafa Z. Younis, Christopher J.L. Murray, Mohsen Naghavi

Epidemiology & Population Health

Research output: Contribution to journal › Article › peer-review

1238 Scopus citations

Abstract

IMPORTANCE: The increasing burden due tocancer and other noncommunicable diseases poses a threat to human development, which has resulted in global political commitments reflected in the Sustainable Development Goals as well as the World Health Organization (WHO) GlobalAction Plan on Non-Communicable Diseases. To determine if these commitments have resulted in improved cancer control, quantitative assessments of the cancer burden are required. OBJECTIVE: To assess the burden for 29 cancer groups over time to provide a framework for policy discussion, resource allocation, and research focus. EVIDENCE REVIEW: Cancer incidence, mortality, years lived with disability, years of life lost, and disability-adjusted life-years (DALYs) were evaluated for 195 countries and territories by age and sex using the Global Burden of Disease study estimation methods. Levels and trends were analyzed over time, as well as by the Sociodemographic Index (SDI). Changes in incident cases were categorized by changes due to epidemiological vs demographic transition. FINDINGS: In 2016, there were 17.2 million cancer cases worldwide and 8.9 million deaths. Cancer cases increased by 28% between 2006 and 2016. The smallestincrease was seen in high SDI countries. Globally, population aging contributed 17%; population growth, 12%; and changes in age-specific rates, -1% to this change. The most common incident cancer globally for men was prostate cancer (1.4 million cases). The leading cause of cancer deaths and DALYs was tracheal, bronchus, and lung cancer (1.2 million deaths and 25.4 million DALYs). For women, the most common incident cancer and the leading cause ofcancer deaths and DALYs was breast cancer (1.7 million incident cases, 535 000 deaths, and 14.9 million DALYs). In 2016, cancer caused 213.2 million DALYs globally for both sexes combined. Between 2006 and 2016, the average annual age-standardized incidence rates for all cancers combined increased in 130 of 195 countries or territories, and the average annual age-standardized death rates decreased within that timeframe in 143 of 195 countries or territories. CONCLUSIONS AND RELEVANCE: Large disparities exist between countries in cancer incidence, deaths, and associated disability. Scaling up cancer prevention and ensuring universal access to cancer care are required for health equity and to fulfill the global commitments for noncommunicable disease and cancer control.

Original language	English (US)
Pages (from-to)	1553-1568
Number of pages	16
Journal	JAMA Oncology
Volume	4
Issue number	11
DOIs	https://doi.org/10.1001/jamaoncol.2018.2706
State	Published - Nov 2018

ASJC Scopus subject areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1001/jamaoncol.2018.2706

Fingerprint

Dive into the research topics of 'Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016 a systematic analysis for the global burden of disease study global burden of disease cancer collaboration'. Together they form a unique fingerprint.

Cite this

Fitzmaurice, C., Akinyemiju, T. F., Al Lami, F. H., Alam, T., Alizadeh-Navaei, R., Allen, C., Alsharif, U., Alvis-Guzman, N., Amini, E., Anderson, B. O., Aremu, O., Artaman, A., Asgedom, S. W., Assadi, R., Atey, T. M. H., Avila-Burgos, L., Awasthi, A., Saleem, H. O., Barac, A., ... Naghavi, M. (2018). Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016 a systematic analysis for the global burden of disease study global burden of disease cancer collaboration. JAMA Oncology, 4(11), 1553-1568. https://doi.org/10.1001/jamaoncol.2018.2706

Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016 a systematic analysis for the global burden of disease study global burden of disease cancer collaboration. / Fitzmaurice, Christina; Akinyemiju, Tomi F.; Al Lami, Faris Hasan et al.
In: JAMA Oncology, Vol. 4, No. 11, 11.2018, p. 1553-1568.

Research output: Contribution to journal › Article › peer-review

Fitzmaurice, C, Akinyemiju, TF, Al Lami, FH, Alam, T, Alizadeh-Navaei, R, Allen, C, Alsharif, U, Alvis-Guzman, N, Amini, E, Anderson, BO, Aremu, O, Artaman, A, Asgedom, SW, Assadi, R, Atey, TMH, Avila-Burgos, L, Awasthi, A, Saleem, HO, Barac, A, Bennett, JR, Bensenor, IM, Bhakta, N, Brenner, H, Cahuana-Hurtado, L, Castañeda-Orjuela, CA, Catalá-López, F, Choi, JYJ, Christopher, DJ, Chung, SC, Curado, MP, Dandona, L, Dandona, R, Das Neves, J, Dey, S, Dharmaratne, SD, Doku, DT, Driscoll, TR, Dubey, M, Ebrahimi, H, Edessa, D, El-Khatib, Z, Endries, AY, Fischer, F, Force, LM, Foreman, KJ, Gebrehiwot, SW, Gopalani, SV, Grosso, G, Gupta, R, Gyawali, B, Hamadeh, RR, Hamidi, S, Harvey, J, Hassen, HY, Hay, RJ, Hay, SI, Heibati, B, Hiluf, MK, Horita, N, Hosgood, HD, Ilesanmi, OS, Innos, K, Islami, F, Jakovljevic, MB, Johnson, SC, Jonas, JB, Kasaeian, A, Kassa, TD, Khader, YS, Khan, EA, Khan, G, Khang, YH, Khosravi, MH, Khubchandani, J, Kopec, JA, Kumar, GA, Kutz, M, Lad, DP, Lafranconi, A, Lan, Q, Legesse, Y, Leigh, J, Linn, S, Lunevicius, R, Majeed, A, Malekzadeh, R, Malta, DC, Mantovani, LG, McMahon, BJ, Meier, T, Melaku, YA, Melku, M, Memiah, P, Mendoza, W, Meretoja, TJ, Mezgebe, HB, Miller, TR, Mohammed, S, Mokdad, AH, Moosazadeh, M, Moraga, P, Mousavi, SM, Nangia, V, Nguyen, CT, Nong, VM, Ogbo, FA, Olagunju, AT, Mahesh, PA, Park, EK, Patel, T, Pereira, DM, Pishgar, F, Postma, MJ, Pourmalek, F, Qorbani, M, Rafay, A, Rawaf, S, Rawaf, DL, Roshandel, G, Safiri, S, Salimzadeh, H, Sanabria, JR, Milicevic, MMS, Sartorius, B, Satpathy, M, Sepanlou, SG, Shackelford, KA, Shaikh, MA, Sharif-Alhoseini, M, She, J, Shin, MJ, Shiue, I, Shrime, MG, Sinke, AH, Sisay, M, Sligar, A, Sufiyan, MB, Sykes, BL, Tabarés-Seisdedos, R, Tessema, GA, Topor-Madry, R, Tran, TT, Tran, BX, Ukwaja, KN, Vlassov, VV, Vollset, SE, Weiderpass, E, Williams, HC, Yimer, NB, Yonemoto, N, Younis, MZ, Murray, CJL & Naghavi, M 2018, 'Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016 a systematic analysis for the global burden of disease study global burden of disease cancer collaboration', JAMA Oncology, vol. 4, no. 11, pp. 1553-1568. https://doi.org/10.1001/jamaoncol.2018.2706

Fitzmaurice C, Akinyemiju TF, Al Lami FH, Alam T, Alizadeh-Navaei R, Allen C et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016 a systematic analysis for the global burden of disease study global burden of disease cancer collaboration. JAMA Oncology. 2018 Nov;4(11):1553-1568. doi: 10.1001/jamaoncol.2018.2706

Fitzmaurice, Christina ; Akinyemiju, Tomi F. ; Al Lami, Faris Hasan et al. / Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016 a systematic analysis for the global burden of disease study global burden of disease cancer collaboration. In: JAMA Oncology. 2018 ; Vol. 4, No. 11. pp. 1553-1568.

@article{906744d96d3a4f5d91af8929e935d42b,

title = "Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016 a systematic analysis for the global burden of disease study global burden of disease cancer collaboration",

abstract = "IMPORTANCE: The increasing burden due tocancer and other noncommunicable diseases poses a threat to human development, which has resulted in global political commitments reflected in the Sustainable Development Goals as well as the World Health Organization (WHO) GlobalAction Plan on Non-Communicable Diseases. To determine if these commitments have resulted in improved cancer control, quantitative assessments of the cancer burden are required. OBJECTIVE: To assess the burden for 29 cancer groups over time to provide a framework for policy discussion, resource allocation, and research focus. EVIDENCE REVIEW: Cancer incidence, mortality, years lived with disability, years of life lost, and disability-adjusted life-years (DALYs) were evaluated for 195 countries and territories by age and sex using the Global Burden of Disease study estimation methods. Levels and trends were analyzed over time, as well as by the Sociodemographic Index (SDI). Changes in incident cases were categorized by changes due to epidemiological vs demographic transition. FINDINGS: In 2016, there were 17.2 million cancer cases worldwide and 8.9 million deaths. Cancer cases increased by 28% between 2006 and 2016. The smallestincrease was seen in high SDI countries. Globally, population aging contributed 17%; population growth, 12%; and changes in age-specific rates, -1% to this change. The most common incident cancer globally for men was prostate cancer (1.4 million cases). The leading cause of cancer deaths and DALYs was tracheal, bronchus, and lung cancer (1.2 million deaths and 25.4 million DALYs). For women, the most common incident cancer and the leading cause ofcancer deaths and DALYs was breast cancer (1.7 million incident cases, 535 000 deaths, and 14.9 million DALYs). In 2016, cancer caused 213.2 million DALYs globally for both sexes combined. Between 2006 and 2016, the average annual age-standardized incidence rates for all cancers combined increased in 130 of 195 countries or territories, and the average annual age-standardized death rates decreased within that timeframe in 143 of 195 countries or territories. CONCLUSIONS AND RELEVANCE: Large disparities exist between countries in cancer incidence, deaths, and associated disability. Scaling up cancer prevention and ensuring universal access to cancer care are required for health equity and to fulfill the global commitments for noncommunicable disease and cancer control.",

author = "Christina Fitzmaurice and Akinyemiju, {Tomi F.} and {Al Lami}, {Faris Hasan} and Tahiya Alam and Reza Alizadeh-Navaei and Christine Allen and Ubai Alsharif and Nelson Alvis-Guzman and Erfan Amini and Anderson, {Benjamin O.} and Olatunde Aremu and Al Artaman and Asgedom, {Solomon Weldegebreal} and Reza Assadi and Atey, {Tesfay Me Hari} and Leticia Avila-Burgos and Ashish Awasthi and Saleem, {Huda Omerba} and Aleksandra Barac and Bennett, {James R.} and Bensenor, {Isabela M.} and Nickhill Bhakta and Hermann Brenner and Lucero Cahuana-Hurtado and Casta{\~n}eda-Orjuela, {Carlos A.} and Ferr{\'a}n Catal{\'a}-L{\'o}pez and Choi, {Jee Young Jasmine} and Christopher, {Devasahayam Jesudas} and Chung, {Sheng Chia} and Curado, {Maria Paula} and Lalit Dandona and Rakhi Dandona and {Das Neves}, Jos{\'e} and Subhojit Dey and Dharmaratne, {Samath D.} and Doku, {David Teye} and Driscoll, {Tim R.} and Manisha Dubey and Hedyeh Ebrahimi and Dumessa Edessa and Ziad El-Khatib and Endries, {Aman Yesuf} and Florian Fischer and Force, {Lisa M.} and Foreman, {Kyle J.} and Gebrehiwot, {Solomon Weldemariam} and Gopalani, {Sameer Vali} and Giuseppe Grosso and Rahul Gupta and Bishal Gyawali and Hamadeh, {Randah Ribhi} and Samer Hamidi and James Harvey and Hassen, {Hamid Yimam} and Hay, {Roderick J.} and Hay, {Simon I.} and Behzad Heibati and Hiluf, {Molla Kahssay} and Nobuyuki Horita and Hosgood, {H. Dean} and Ilesanmi, {Olayinka S.} and Kaire Innos and Farhad Islami and Jakovljevic, {Mihajlo B.} and Johnson, {Sarah Charlotte} and Jonas, {Jost B.} and Amir Kasaeian and Kassa, {Tesfaye Dessale} and Khader, {Yousef Saleh} and Khan, {Ejaz Ahmad} and Gulfaraz Khan and Khang, {Young Ho} and Khosravi, {Mohammad Hossein} and Jagdish Khubchandani and Kopec, {Jacek A.} and Kumar, {G. Anil} and Michael Kutz and Lad, {Deepesh Pravinkumar} and Alessandra Lafranconi and Qing Lan and Yirga Legesse and James Leigh and Shai Linn and Raimundas Lunevicius and Azeem Majeed and Reza Malekzadeh and Malta, {Deborah Carvalho} and Mantovani, {Lorenzo G.} and McMahon, {Brian J.} and Toni Meier and Melaku, {Yohannes Adama} and Mulugeta Melku and Peter Memiah and Walter Mendoza and Meretoja, {Tuomo J.} and Mezgebe, {Haftay Berhane} and Miller, {Ted R.} and Shafiu Mohammed and Mokdad, {Ali H.} and Mahmood Moosazadeh and Paula Moraga and Mousavi, {Seyyed Meysam} and Vinay Nangia and Nguyen, {Cuong Tat} and Nong, {Vuong Minh} and Ogbo, {Felix Akpojene} and Olagunju, {Andrew Toyin} and Mahesh, {P. A.} and Park, {Eun Kee} and Tejas Patel and Pereira, {David M.} and Farhad Pishgar and Postma, {Maarten J.} and Farshad Pourmalek and Mostafa Qorbani and Anwar Rafay and Salman Rawaf and Rawaf, {David Laith} and Gholamreza Roshandel and Saeid Safiri and Hamideh Salimzadeh and Sanabria, {Juan Ramon} and Milicevic, {Milena M.Santric} and Benn Sartorius and Maheswar Satpathy and Sepanlou, {Sadaf G.} and Shackelford, {Katya Anne} and Shaikh, {Masood Ali} and Mahdi Sharif-Alhoseini and Jun She and Shin, {Min Jeong} and Ivy Shiue and Shrime, {Mark G.} and Sinke, {Abiy Hiruye} and Mekonnen Sisay and Amber Sligar and Sufiyan, {Muawiyyah Babale} and Sykes, {Bryan L.} and Rafael Tabar{\'e}s-Seisdedos and Tessema, {Gizachew Assefa} and Roman Topor-Madry and Tran, {Tung Thanh} and Tran, {Bach Xuan} and Ukwaja, {Kingsley Nnanna} and Vlassov, {Vasiliy Victorovich} and Vollset, {Stein Emil} and Elisabete Weiderpass and Williams, {Hywel C.} and Yimer, {Nigus Bililign} and Naohiro Yonemoto and Younis, {Mustafa Z.} and Murray, {Christopher J.L.} and Mohsen Naghavi",

year = "2018",

month = nov,

doi = "10.1001/jamaoncol.2018.2706",

language = "English (US)",

volume = "4",

pages = "1553--1568",

journal = "JAMA Oncology",

issn = "2374-2437",

publisher = "American Medical Association",

number = "11",

}

TY - JOUR

T1 - Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016 a systematic analysis for the global burden of disease study global burden of disease cancer collaboration

AU - Fitzmaurice, Christina

AU - Akinyemiju, Tomi F.

AU - Al Lami, Faris Hasan

AU - Alam, Tahiya

AU - Alizadeh-Navaei, Reza

AU - Allen, Christine

AU - Alsharif, Ubai

AU - Alvis-Guzman, Nelson

AU - Amini, Erfan

AU - Anderson, Benjamin O.

AU - Aremu, Olatunde

AU - Artaman, Al

AU - Asgedom, Solomon Weldegebreal

AU - Assadi, Reza

AU - Atey, Tesfay Me Hari

AU - Avila-Burgos, Leticia

AU - Awasthi, Ashish

AU - Saleem, Huda Omerba

AU - Barac, Aleksandra

AU - Bennett, James R.

AU - Bensenor, Isabela M.

AU - Bhakta, Nickhill

AU - Brenner, Hermann

AU - Cahuana-Hurtado, Lucero

AU - Castañeda-Orjuela, Carlos A.

AU - Catalá-López, Ferrán

AU - Choi, Jee Young Jasmine

AU - Christopher, Devasahayam Jesudas

AU - Chung, Sheng Chia

AU - Curado, Maria Paula

AU - Dandona, Lalit

AU - Dandona, Rakhi

AU - Das Neves, José

AU - Dey, Subhojit

AU - Dharmaratne, Samath D.

AU - Doku, David Teye

AU - Driscoll, Tim R.

AU - Dubey, Manisha

AU - Ebrahimi, Hedyeh

AU - Edessa, Dumessa

AU - El-Khatib, Ziad

AU - Endries, Aman Yesuf

AU - Fischer, Florian

AU - Force, Lisa M.

AU - Foreman, Kyle J.

AU - Gebrehiwot, Solomon Weldemariam

AU - Gopalani, Sameer Vali

AU - Grosso, Giuseppe

AU - Gupta, Rahul

AU - Gyawali, Bishal

AU - Hamadeh, Randah Ribhi

AU - Hamidi, Samer

AU - Harvey, James

AU - Hassen, Hamid Yimam

AU - Hay, Roderick J.

AU - Hay, Simon I.

AU - Heibati, Behzad

AU - Hiluf, Molla Kahssay

AU - Horita, Nobuyuki

AU - Hosgood, H. Dean

AU - Ilesanmi, Olayinka S.

AU - Innos, Kaire

AU - Islami, Farhad

AU - Jakovljevic, Mihajlo B.

AU - Johnson, Sarah Charlotte

AU - Jonas, Jost B.

AU - Kasaeian, Amir

AU - Kassa, Tesfaye Dessale

AU - Khader, Yousef Saleh

AU - Khan, Ejaz Ahmad

AU - Khan, Gulfaraz

AU - Khang, Young Ho

AU - Khosravi, Mohammad Hossein

AU - Khubchandani, Jagdish

AU - Kopec, Jacek A.

AU - Kumar, G. Anil

AU - Kutz, Michael

AU - Lad, Deepesh Pravinkumar

AU - Lafranconi, Alessandra

AU - Lan, Qing

AU - Legesse, Yirga

AU - Leigh, James

AU - Linn, Shai

AU - Lunevicius, Raimundas

AU - Majeed, Azeem

AU - Malekzadeh, Reza

AU - Malta, Deborah Carvalho

AU - Mantovani, Lorenzo G.

AU - McMahon, Brian J.

AU - Meier, Toni

AU - Melaku, Yohannes Adama

AU - Melku, Mulugeta

AU - Memiah, Peter

AU - Mendoza, Walter

AU - Meretoja, Tuomo J.

AU - Mezgebe, Haftay Berhane

AU - Miller, Ted R.

AU - Mohammed, Shafiu

AU - Mokdad, Ali H.

AU - Moosazadeh, Mahmood

AU - Moraga, Paula

AU - Mousavi, Seyyed Meysam

AU - Nangia, Vinay

AU - Nguyen, Cuong Tat

AU - Nong, Vuong Minh

AU - Ogbo, Felix Akpojene

AU - Olagunju, Andrew Toyin

AU - Mahesh, P. A.

AU - Park, Eun Kee

AU - Patel, Tejas

AU - Pereira, David M.

AU - Pishgar, Farhad

AU - Postma, Maarten J.

AU - Pourmalek, Farshad

AU - Qorbani, Mostafa

AU - Rafay, Anwar

AU - Rawaf, Salman

AU - Rawaf, David Laith

AU - Roshandel, Gholamreza

AU - Safiri, Saeid

AU - Salimzadeh, Hamideh

AU - Sanabria, Juan Ramon

AU - Milicevic, Milena M.Santric

AU - Sartorius, Benn

AU - Satpathy, Maheswar

AU - Sepanlou, Sadaf G.

AU - Shackelford, Katya Anne

AU - Shaikh, Masood Ali

AU - Sharif-Alhoseini, Mahdi

AU - She, Jun

AU - Shin, Min Jeong

AU - Shiue, Ivy

AU - Shrime, Mark G.

AU - Sinke, Abiy Hiruye

AU - Sisay, Mekonnen

AU - Sligar, Amber

AU - Sufiyan, Muawiyyah Babale

AU - Sykes, Bryan L.

AU - Tabarés-Seisdedos, Rafael

AU - Tessema, Gizachew Assefa

AU - Topor-Madry, Roman

AU - Tran, Tung Thanh

AU - Tran, Bach Xuan

AU - Ukwaja, Kingsley Nnanna

AU - Vlassov, Vasiliy Victorovich

AU - Vollset, Stein Emil

AU - Weiderpass, Elisabete

AU - Williams, Hywel C.

AU - Yimer, Nigus Bililign

AU - Yonemoto, Naohiro

AU - Younis, Mustafa Z.

AU - Murray, Christopher J.L.

AU - Naghavi, Mohsen

PY - 2018/11

Y1 - 2018/11

N2 - IMPORTANCE: The increasing burden due tocancer and other noncommunicable diseases poses a threat to human development, which has resulted in global political commitments reflected in the Sustainable Development Goals as well as the World Health Organization (WHO) GlobalAction Plan on Non-Communicable Diseases. To determine if these commitments have resulted in improved cancer control, quantitative assessments of the cancer burden are required. OBJECTIVE: To assess the burden for 29 cancer groups over time to provide a framework for policy discussion, resource allocation, and research focus. EVIDENCE REVIEW: Cancer incidence, mortality, years lived with disability, years of life lost, and disability-adjusted life-years (DALYs) were evaluated for 195 countries and territories by age and sex using the Global Burden of Disease study estimation methods. Levels and trends were analyzed over time, as well as by the Sociodemographic Index (SDI). Changes in incident cases were categorized by changes due to epidemiological vs demographic transition. FINDINGS: In 2016, there were 17.2 million cancer cases worldwide and 8.9 million deaths. Cancer cases increased by 28% between 2006 and 2016. The smallestincrease was seen in high SDI countries. Globally, population aging contributed 17%; population growth, 12%; and changes in age-specific rates, -1% to this change. The most common incident cancer globally for men was prostate cancer (1.4 million cases). The leading cause of cancer deaths and DALYs was tracheal, bronchus, and lung cancer (1.2 million deaths and 25.4 million DALYs). For women, the most common incident cancer and the leading cause ofcancer deaths and DALYs was breast cancer (1.7 million incident cases, 535 000 deaths, and 14.9 million DALYs). In 2016, cancer caused 213.2 million DALYs globally for both sexes combined. Between 2006 and 2016, the average annual age-standardized incidence rates for all cancers combined increased in 130 of 195 countries or territories, and the average annual age-standardized death rates decreased within that timeframe in 143 of 195 countries or territories. CONCLUSIONS AND RELEVANCE: Large disparities exist between countries in cancer incidence, deaths, and associated disability. Scaling up cancer prevention and ensuring universal access to cancer care are required for health equity and to fulfill the global commitments for noncommunicable disease and cancer control.

AB - IMPORTANCE: The increasing burden due tocancer and other noncommunicable diseases poses a threat to human development, which has resulted in global political commitments reflected in the Sustainable Development Goals as well as the World Health Organization (WHO) GlobalAction Plan on Non-Communicable Diseases. To determine if these commitments have resulted in improved cancer control, quantitative assessments of the cancer burden are required. OBJECTIVE: To assess the burden for 29 cancer groups over time to provide a framework for policy discussion, resource allocation, and research focus. EVIDENCE REVIEW: Cancer incidence, mortality, years lived with disability, years of life lost, and disability-adjusted life-years (DALYs) were evaluated for 195 countries and territories by age and sex using the Global Burden of Disease study estimation methods. Levels and trends were analyzed over time, as well as by the Sociodemographic Index (SDI). Changes in incident cases were categorized by changes due to epidemiological vs demographic transition. FINDINGS: In 2016, there were 17.2 million cancer cases worldwide and 8.9 million deaths. Cancer cases increased by 28% between 2006 and 2016. The smallestincrease was seen in high SDI countries. Globally, population aging contributed 17%; population growth, 12%; and changes in age-specific rates, -1% to this change. The most common incident cancer globally for men was prostate cancer (1.4 million cases). The leading cause of cancer deaths and DALYs was tracheal, bronchus, and lung cancer (1.2 million deaths and 25.4 million DALYs). For women, the most common incident cancer and the leading cause ofcancer deaths and DALYs was breast cancer (1.7 million incident cases, 535 000 deaths, and 14.9 million DALYs). In 2016, cancer caused 213.2 million DALYs globally for both sexes combined. Between 2006 and 2016, the average annual age-standardized incidence rates for all cancers combined increased in 130 of 195 countries or territories, and the average annual age-standardized death rates decreased within that timeframe in 143 of 195 countries or territories. CONCLUSIONS AND RELEVANCE: Large disparities exist between countries in cancer incidence, deaths, and associated disability. Scaling up cancer prevention and ensuring universal access to cancer care are required for health equity and to fulfill the global commitments for noncommunicable disease and cancer control.

UR - http://www.scopus.com/inward/record.url?scp=85055941761&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055941761&partnerID=8YFLogxK

U2 - 10.1001/jamaoncol.2018.2706

DO - 10.1001/jamaoncol.2018.2706

M3 - Article

C2 - 29860482

AN - SCOPUS:85055941761

SN - 2374-2437

VL - 4

SP - 1553

EP - 1568

JO - JAMA Oncology

JF - JAMA Oncology

IS - 11

ER -

Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016 a systematic analysis for the global burden of disease study global burden of disease cancer collaboration

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this